======= PSME1 ======= == Gene Information == * **Official Symbol**: PSME1 * **Official Name**: proteasome activator subunit 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=5720|5720]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q06323|Q06323]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PSME1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PSME1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/600654|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Implicated in immunoproteasome assembly and required for efficient antigen processing. The PA28 activator complex enhances the generation of class I binding peptides by altering the cleavage pattern of the proteasome. |PA28 alpha| |PA28 beta| |proteasome activator complex| |endopeptidase activator activity| |proteasome complex| |regulation of cellular amino acid metabolic process| |regulation of hematopoietic stem cell differentiation| |antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent| |regulation of transcription from RNA polymerase II promoter in response to hypoxia| |antigen processing and presentation of exogenous peptide antigen via MHC class I| |NIK/NF-kappaB signaling| |regulation of cellular amine metabolic process| |anaphase-promoting complex-dependent catabolic process| |regulation of hematopoietic progenitor cell differentiation| |negative regulation of G2/M transition of mitotic cell cycle| |SCF-dependent proteasomal ubiquitin-dependent protein catabolic process| |interleukin-1-mediated signaling pathway| |Wnt signaling pathway, planar cell polarity pathway| |antigen processing and presentation of peptide antigen via MHC class I| |negative regulation of cell cycle G2/M phase transition| |regulation of establishment of planar polarity| |stimulatory C-type lectin receptor signaling pathway| |innate immune response activating cell surface receptor signaling pathway| |regulation of stem cell differentiation| |tumor necrosis factor-mediated signaling pathway| |regulation of transcription from RNA polymerase II promoter in response to stress| |regulation of DNA-templated transcription in response to stress| |non-canonical Wnt signaling pathway| |positive regulation of canonical Wnt signaling pathway| |regulation of G1/S transition of mitotic cell cycle| |regulation of cell cycle G1/S phase transition| |regulation of cellular ketone metabolic process| |positive regulation of endopeptidase activity| |Fc-epsilon receptor signaling pathway| |cellular response to interleukin-1| |negative regulation of canonical Wnt signaling pathway| |T cell receptor signaling pathway| |antigen processing and presentation of exogenous peptide antigen| |positive regulation of Wnt signaling pathway| |regulation of mRNA stability| |regulation of morphogenesis of an epithelium| |antigen processing and presentation of exogenous antigen| |regulation of proteasomal protein catabolic process| |regulation of RNA stability| |cellular response to hypoxia| |antigen processing and presentation of peptide antigen| |positive regulation of peptidase activity| |regulation of G2/M transition of mitotic cell cycle| |cellular response to decreased oxygen levels| |response to interleukin-1| |regulation of mRNA catabolic process| |negative regulation of Wnt signaling pathway| |regulation of cell cycle G2/M phase transition| |negative regulation of mitotic cell cycle phase transition| |cellular response to oxygen levels| |regulation of proteolysis involved in cellular protein catabolic process| |antigen processing and presentation| |negative regulation of cell cycle phase transition| |innate immune response-activating signal transduction| |cellular response to tumor necrosis factor| |Fc receptor signaling pathway| |regulation of cellular protein catabolic process| |regulation of animal organ morphogenesis| |activation of innate immune response| |response to tumor necrosis factor| |protein deubiquitination| |regulation of canonical Wnt signaling pathway| |antigen receptor-mediated signaling pathway| |protein modification by small protein removal| |protein polyubiquitination| |negative regulation of mitotic cell cycle| |proteasome-mediated ubiquitin-dependent protein catabolic process| |negative regulation of cell cycle process| |regulation of mRNA metabolic process| |positive regulation of innate immune response| |response to hypoxia| |proteasomal protein catabolic process| |Wnt signaling pathway| |response to decreased oxygen levels| |positive regulation of proteolysis| |cell-cell signaling by wnt| |regulation of Wnt signaling pathway| |post-translational protein modification| |positive regulation of response to biotic stimulus| |MAPK cascade| |response to oxygen levels| |regulation of protein catabolic process| |signal transduction by protein phosphorylation| |regulation of mitotic cell cycle phase transition| |regulation of endopeptidase activity| |regulation of small molecule metabolic process| |cell surface receptor signaling pathway involved in cell-cell signaling| |regulation of peptidase activity| |regulation of cell cycle phase transition| |immune response-activating cell surface receptor signaling pathway| |regulation of hemopoiesis| |regulation of innate immune response| |positive regulation of defense response| |immune response-regulating cell surface receptor signaling pathway| |positive regulation of multi-organism process| |regulation of response to biotic stimulus| |posttranscriptional regulation of gene expression| |ubiquitin-dependent protein catabolic process| |modification-dependent protein catabolic process| |modification-dependent macromolecule catabolic process| |immune response-activating signal transduction| |negative regulation of cell cycle| |proteolysis involved in cellular protein catabolic process| |immune response-regulating signaling pathway| |positive regulation of response to external stimulus| |cellular protein catabolic process| |regulation of mitotic cell cycle| |activation of immune response| |cytokine-mediated signaling pathway| |protein catabolic process| |protein ubiquitination| |regulation of proteolysis| |regulation of cell cycle process| |regulation of defense response| |positive regulation of hydrolase activity| |protein modification by small protein conjugation| |regulation of multi-organism process| |regulation of cellular catabolic process| |positive regulation of immune response| |cellular macromolecule catabolic process| |protein phosphorylation| |protein modification by small protein conjugation or removal| |regulation of catabolic process| |cellular response to cytokine stimulus| |macromolecule catabolic process| |organonitrogen compound catabolic process| |regulation of anatomical structure morphogenesis| |regulation of response to external stimulus| |response to cytokine| |cell-cell signaling| |regulation of immune response| |positive regulation of immune system process| |response to abiotic stimulus| |regulation of cell cycle| |negative regulation of signal transduction| |proteolysis| |transmembrane transport| |regulation of hydrolase activity| |phosphorylation| |negative regulation of cell communication| |negative regulation of signaling| |positive regulation of catalytic activity| |regulation of response to stress| |positive regulation of cellular protein metabolic process| |negative regulation of response to stimulus| |positive regulation of signal transduction| |regulation of immune system process| |intracellular signal transduction| |cellular response to stress| |positive regulation of protein metabolic process| |organic substance catabolic process| |positive regulation of molecular function| |cellular catabolic process| |regulation of cell differentiation| |positive regulation of cell communication| |positive regulation of signaling| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|-1.84| |[[:results:exp190|Vincristine 0.0005μM R04 exp190]]|1.77| |[[:results:exp317|Geldanamycin 0.015 to 0.05μM on day4 R07 exp317]]|1.83| |[[:results:exp391|Pomalidomide 20μM R07 exp391]]|1.91| |[[:results:exp3|Actinomycin-D 0.001μM R00 exp3]]|1.95| ^Gene^Correlation^ |[[:human genes:h:hars|HARS]]|0.44| Global Fraction of Cell Lines Where Essential: 61/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|4/28| |blood|4/28| |bone|1/26| |breast|4/33| |central nervous system|3/56| |cervix|0/4| |colorectal|3/17| |esophagus|2/13| |fibroblast|0/1| |gastric|0/16| |kidney|4/21| |liver|0/20| |lung|5/75| |lymphocyte|0/16| |ovary|1/26| |pancreas|0/24| |peripheral nervous system|4/16| |plasma cell|0/15| |prostate|0/1| |skin|3/24| |soft tissue|1/9| |thyroid|0/2| |upper aerodigestive|2/22| |urinary tract|0/29| |uterus|1/5| == Essentiality in NALM6 == * **Essentiality Rank**: 12907 * **Expression level (log2 read counts)**: 7.23 {{:chemogenomics:nalm6 dist.png?nolink |}}